The patent-pending assay measures changes in red blood cell membrane rigidity to identify elevated bile acids, a potential early marker of liver disease.
Researchers at the University of Toledo developed a rapid blood screening method to detect elevated bile acids, an early marker of liver disease that is often omitted from routine diagnostic panels.
The method, which is currently patent-pending, aims to identify liver dysfunction before symptoms such as jaundice, fatigue, and abdominal discomfort appear. While standard blood panels typically measure cholesterol, blood glucose, and triglycerides, they do not routinely include bile acids, according to the researchers…